Consider a safe alternative to open-heart surgery with our same-day personalized treatment plans and minimally invasive treatments.
Among the Best in the U.S. for Heart Care
U.S. News & World Report ranked RUSH University Medical Center among the best in the nation for heart care.
The Rush Approach to Structural Heart Disease Care
Whether you're older or dealing with illness or birth defects, you may not think your heart valve problem can be treated. But thanks to our advanced technology and devices, we can treat you for these conditions through minimally invasive procedures rather than open-heart surgeries, regardless of how old or sick you may be.
And these procedures mean you can expect faster recoveries, less pain and, typically, less cardiac rehab. No matter the case, Rush structural heart specialists will work together to thoroughly evaluate you and present personalized treatment plans the very same day.
Rush Excellence in Structural Heart Disease Care
- Minimally invasive procedures: The treatment of valvular heart disease through minimally invasive catheter-based procedures. That means faster recoveries, less rehab and less pain for you. We have extensive expertise in TAVR (transcatheter aortic valve replacement), which involves replacing the aortic valve without needing open-heart surgery. We also offer MitraClip if you have severe leakage in your mitral valve. Given the minimally invasive nature, these are ideal treatment options if you're not eligible for traditional surgery.
- Same-day treatment plans: You will meet with a team of specialists — including an interventional cardiologist and a cardiac surgeon — at the same time. Drawing on their many years of experience, these specialists develop an individualized treatment plan and present it to you on the same day.
- Access to up-and-coming treatments and trials: Rush's heart valve specialists have been leaders in clinical trials, bringing you innovative treatments, including transaortic valve replacement (TAVR), MitraClip and the CoreValve. They continue to participate in research and clinical trials aimed at helping people with heart valve disease lead longer, fuller lives.